CUPR Market Analysis
Overview
Price chart · mood · technical indicatorsFundamentals
Updated daily after market closeP/E ratio—
EPS (TTM)$-0.180.0% YoY
Profit margin0.0%HEALTHCARE
Market cap$5.4MMicro cap
Valuation
- Forward P/E
- —
- PEG ratio
- —
- P/B
- 1.37
- P/S (TTM)
- 108.42
- EV/EBITDA
- —
Profitability & growth
- ROE (TTM)
- -1569.0%
- Operating margin
- -10568.0%
- Revenue growth YoY
- 267.4%
- Dividend yield
- —
- Beta
- —
Last earnings
Dec 9, 2025 · Estimate $0.00 · Reported $-0.10
Analyst estimate. Actual results often differ.
Ratios are point-in-time. Historical metrics — no guarantees about what comes next.
News & Sentiment
36 articles · sorted by datePage 1 of 2 · 36 total
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
About Cuprina Holdings (Cayman) Limited Class A Ordinary Shares
Company profileCuprina Holdings (Cayman) Limited, a biomedical and biotechnology company, focuses on the development and commercialization of products for the management of chronic wounds.
Classification
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Exchange
- NASDAQ
- Country
- USA
- Currency
- USD
Company profile
- HQ
- BLK 1090, SINGAPORE, SINGAPORE
- Fiscal year end
- December
- Latest quarter
- Dec 31, 2025
Market cap$5.4M
Shares outstanding$7.4M
52W high$9.50
52W low$0.24
Educational content · Not investment advice or recommendations
We're educators, not advisors. Your decisions are your own. Disclaimer
B
Agent
The AI built for clarity
I'm your AI thinking companion for the markets — I can help you explore and learn, but I'm not a financial advisor. Everything here is educational. Disclaimer
B
Agent